Oxidative stress as a mechanism of valproic acid-associated hepatotoxicity

被引：112

作者：

Chang, Thomas K. H. ^{[1
]}

Abbott, Frank S. ^{[1
]}

机构：

[1] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC V6T 1Z3, Canada

来源：

DRUG METABOLISM REVIEWS | 2006年 / 38卷 / 04期

关键词：

alpha-fluoro-valproic acid; hepatotoxicity; oxidative stress; reactive oxygen species; valproic acid;

D O I：

10.1080/03602530600959433

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Valproic acid (2-n-propylpentanoic acid; VPA) has several therapeutic indications, but it is used primarily as all anticonvulsant. VPA is a relatively safe drug, but its use is associated with idiosyncratic hepatotoxicity, which in some cases may lead to fatality. The underlying mechanism responsible for the hepatotoxicity is still not well understood, but various hypotheses have been proposed, including oxidative stress. This article discusses the experimental evidence oil the effect of VPA oil the various indices of oxidative stress and oil the potential role of oxidative stress in VPA-associated hepatotoxicity.

引用

页码：627 / 639

页数：13

共 89 条

[1]

Abbott F.S., 1999, MIL DRUG TH, P47

[2] Method to overcome photoreaction, a serious drawback to the use of dichlorofluorescin in evaluation of reactive oxygen species [J].

Afzal, M ;

Matsugo, S ;

Sasai, M ;

Xu, BH ;

Aoyama, K ;

Takeuchi, T .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 304 (04) :619-624

[3] THE HIGH-INCIDENCE OF VALPROATE HEPATOTOXICITY IN INFANTS MAY RELATE TO FAMILIAL METABOLIC DEFECTS [J].

APPLETON, RE ;

FARRELL, K ;

APPLEGARTH, DA ;

DIMMICK, JE ;

WONG, LTK ;

DAVIDSON, AGF .

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1990, 17 (02) :145-148

[4]

BASS DA, 1983, J IMMUNOL, V130, P1910

[5] INHIBITION OF MEDIUM-CHAIN FATTY-ACID BETA-OXIDATION INVITRO BY VALPROIC ACID AND ITS UNSATURATED METABOLITE, 2-NORMAL-PROPYL-4-PENTENOIC ACID [J].

BJORGE, SM ;

BAILLIE, TA .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 132 (01) :245-252

[6] Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity [J].

Boelsterli, UA .

TOXICOLOGY AND APPLIED PHARMACOLOGY, 2003, 192 (03) :307-322

[7] Valproic acid hepatic fatalities .3. US experience since 1986 [J].

Bryant, AE ;

Dreifuss, FE .

NEUROLOGY, 1996, 46 (02) :465-469

[8] PROTECTION AGAINST SODIUM VALPROATE INJURY IN ISOLATED HEPATOCYTES BY ALPHA-TOCOPHEROL AND "N,N'-DIPHENYL-PARA-PHENYLENEDIAMINE [J].

BUCHI, KN ;

GRAY, PD ;

ROLLINS, DE ;

TOLMAN, KG .

JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 24 (04) :148-154

[9] Cytochrome c is a potent catalyst of dichlorofluorescin oxidation:: Implications for the role of reactive oxygen species in apoptosis [J].

Burkitt, MJ ;

Wardman, P .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 282 (01) :329-333

[10] Surveillance for fatal suspected adverse drug reactions in the UK [J].

Clarkson, A ;

Choonara, I .

ARCHIVES OF DISEASE IN CHILDHOOD, 2002, 87 (06) :462-466

← 1 2 3 4 5 6 7 8 9 →